5-HT2C receptor activation decreases appetite and body weight in obese subjects
about
Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3)Conformational analysis of the anti-obesity drug lorcaserin in water: how to take advantage of long-range residual dipolar couplings.Weight outcomes among antidepressant users in nursing facilities.Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X.Do allelic variants of SLC6A14 predispose to obesity?Separate systems for serotonin and leptin in appetite control.5-HT2C receptor modulation and the treatment of obesity.Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.The potential use of selective 5-HT2C agonists in treating obesity.Profile of aripiprazole in the treatment of bipolar disorder in children and adolescentsWe Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.Psychiatric medication induced obesity: an aetiologic review.Preventive treatment of migraine: effect on weight.Efficacy and safety of aripiprazole in child and adolescent patientsDoes weight loss prognosis depend on genetic make-up?Psychological underpinnings of metabolic syndrome.Evaluating pharmacological models of high and low anxiety in sheepInvestigational therapies in the treatment of obesity.Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.Genotype-specific weight loss treatment advice: how close are we?Lorcaserin for the treatment of obesitySerotonergic anti-obesity agents: past experience and future prospects.Use of aripiprazole for delirium in the elderly: a short review.Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum.Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa.Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration.Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function.Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.Tonic regulation of satiety by 5-HT receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies?Alteration in plasma corticosterone levels following long term oral administration of lead produces depression like symptoms in rats.Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers.Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.No evidence of association between the serotonin 2A receptor--1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study.Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective [Formula: see text] agonists.EFFICIENT SYNTHESIS OF THE 5-HT2C RECEPTOR AGONIST, ORG 37684
P2860
Q26783258-E1CA59A1-CC94-4B07-8A12-9FCE422EECB8Q30672639-3E6F074E-E93C-4FA8-93A6-B33D9F848625Q32028083-8466CE3C-41EA-4098-8ABB-8CFAAAEF0E14Q33450573-B5D2153B-5A67-4CFB-9C49-1D9C76C572D1Q33630569-FCC611F3-2125-4A19-A435-AF52A31DEEE5Q33924610-1C5B5675-FE31-4BB4-A007-06860E2ECF44Q33936081-B0E0972E-C78D-4947-A73A-5DB06A6D482AQ34413008-D86A93B2-3972-4567-A6DA-9999F4B8C151Q34497896-83D31980-BA7C-4ABF-AA82-AAEC1DE5ED5EQ34600500-5C06BB0D-F678-4D44-A7E9-D8C5C216431DQ35823591-6F81D819-5F02-4D82-A5BF-810389AEB90FQ35831682-F64048D6-8DEF-40E6-8686-760091EBE6C0Q35987931-910C0DE7-3134-4B3C-9C90-5633FC241461Q36075828-EAF9A707-2BE0-4DFC-A2BB-C6A45EBB4655Q36100777-084B3A62-4962-49F3-93B6-1188AD1EEC8BQ36209843-D16C39F6-BC3D-45F2-93FF-7E99A4B55767Q36402156-83FD3F0F-F356-4FC5-9276-293B18363F6EQ36543067-A529E0E5-421D-4E8B-B6C1-304C7A925D87Q36709588-97DFA63E-452A-4A77-BD71-82B545E10FBAQ36825609-568AF1A5-B7DB-4792-83F5-A88E01047AB0Q37172259-ED67E801-90D3-42D8-B8A9-BF335A514369Q37956399-67055B86-623C-475F-A673-FA39B78AB169Q38290683-4ABE4014-F475-4691-ACF1-AD268F5275F8Q39768889-1CA79655-BD52-4252-893C-515C87DDC6D9Q40482498-F0272839-4B36-41DE-B966-75A4EFDC7542Q41835936-86BF3787-C242-4D00-A4E0-BB485475A383Q42494096-AB5FDA55-0A92-4FDE-AB22-37F4F72E57DCQ42647430-9D93B9CC-4F82-48E6-BCD1-39A0D9000B37Q43025657-735C4F7F-C61C-480C-8CA9-19CAFEDFFF88Q43663440-889A67D9-C279-499B-A9F6-8DB66615CD64Q44183613-BFBB2440-78B8-4CA6-87F6-240635D12C87Q44282784-7B004E01-D617-4DC5-B3AC-D3459B3F9575Q44400212-BA63B19F-C235-4C8D-9FFB-F8EDA621FB98Q44925261-D684C520-2311-400E-9353-7042A8190391Q44926592-12F98A4D-847C-4177-9C84-72B1DD3723A0Q44992845-F3BF0827-2E75-4301-B91C-A5D213FCE53DQ46015738-66CD736F-0876-4E57-AF92-4E7879201BDDQ46955103-7BAA142D-CDE4-4000-B6B6-2B64F2BE6B43Q53251686-6B6E65D0-9AA4-4D5B-BFB8-C2ABCB58EFE6Q56778759-CF693603-9DB7-4C9E-AB6D-B3AC20DCC3E8
P2860
5-HT2C receptor activation decreases appetite and body weight in obese subjects
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@ast
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@en
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@nl
type
label
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@ast
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@en
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@nl
prefLabel
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@ast
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@en
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@nl
P2093
P356
P1433
P1476
5-HT2C receptor activation decreases appetite and body weight in obese subjects
@en
P2093
A L Sharpley
C Williams
E M Goodall
P A Sargent
P2888
P304
P356
10.1007/S002130050407
P407
P577
1997-10-01T00:00:00Z
P5875
P6179
1028209249